XTL Names Mr. Noam Band as its New Chief Executive Officer

Company Overview - XTL Biopharmaceuticals Ltd. has appointed Noam Band as the new Chief Executive Officer, with Shlomo Shalev continuing as Chairman of the Board [2][4] - The company holds 100% of The Social Proxy Ltd., a web data company, and has sublicensed an IP portfolio related to hCDR1 for Lupus treatment [5] Leadership Experience - Noam Band has extensive managerial experience, having served as CEO of Gix Internet Ltd. and Dotomi, and as a board advisor to 7digital Group plc [3] - His background includes expertise in strategic business development, market expansion, and operational leadership, which is expected to benefit XTL's growth and innovation [4] Strategic Direction - The Board of Directors expresses confidence in Band's leadership to drive XTL towards new opportunities and continued success, emphasizing a commitment to innovation and operational excellence [4]